Aspirus Heart & Vascular Institute First in Wisconsin to Implant Coapsys Heart Device
Wausau, Wis. (PRWEB) May 5, 2008 -- Aspirus Heart & Vascular Institute (http://www.aspirus.org/ourServices/index.cfm?catID=1&subCatID=7&pageID=7) surgeon Fernando A. Riveron, M.D. has successfully implanted the first Coapsys® device in Wisconsin.
Aspirus (http://www.aspirus.org) joins 21 other sites nationwide - including New York University Medical Center, Duke University Medical Center and the Cleveland Clinic - in evaluating the safety and effectiveness of the Myocor® Coapsys System (http://www.myocor.com/index.php) through an FDA research study and clinical trial. The new device is intended to reduce the amount of improper blood flow in the heart, improve cardiac function and potentially reduce the cost of heart care for a growing number of people suffering with valve problems.
'Mitral valve insufficiency or mitral regurgitation is a condition in which the mitral valve does not adequately close, resulting in the blood flowing backward,' Dr. Riveron (http://www.aspirus.org/hospitalsClinics/index.cfm?catid=2&subcatID=16&pageid=234&docID=10) said. 'This backward flow causes the heart to work harder, and can result in shortness of breath, decreased energy, generalized weakness and fluid retention.'
Mitral regurgitation is an increasingly common health concern. According to the National Library of Medicine, some degree of mitral regurgitation is found in almost 20 percent of men and women who have an echocardiogram after the age of 55. Valve repair or replacement surgery often can help, but it fails to address the root cause of the problem the way researchers hope the implant can.
The implant procedure involves the placement of two pads that sit on the surface of the heart with a cord passing between them and through the left ventricle. Surgeons draw the pads together in tiny increments, which reshapes the left ventricle and improves heart function. The procedure is less invasive than traditional open-heart surgery because it doesn't require doctors to stop the heart or use large incisions.
"The option to repair the valve (http://www.americanheart.org/presenter.jhtml?identifier=4598) without having to open the heart or use cardiopulmonary bypass may be very beneficial to these patients," Dr. Riveron said.
His first patient, an 80-year-old man from Wisconsin Rapids, viewed the procedure as an opportunity to help others and as a new chance for improving the quality of his life when other treatment options weren't favorable.
The research study, RESTOR-MV (Randomized Evaluation of a Surgical Treatment for Off-pump Repair for the Mitral Valve), is a prospective, randomized clinical trial that will include up to 250 patients. Aspirus is a participant because it has a high quality research program (http://www.aspirus.org/ourServices/index.cfm?catID=1&subCatID=7&pageID=79) and has surgeons experienced in performing valve and beating-heart procedures (http://www.aspirus.org/ourServices/index.cfm?catID=1&subCatID=7&pageID=73).
The AHVI is located at Aspirus Wausau Hospital, a 2008 HealthGrades Distinguished Hospital for Clinical Excellence ranking in the top 5 percent in the nation for overall clinical quality. It is the fifth consecutive year Aspirus has made the list, the only hospital in Wisconsin - and one of just 63 in the nation - with that distinction.
According to the Tenth Annual HealthGrades Hospital Quality in America Study issued in fall 2007, Aspirus Wausau Hospital ranks No. 1 in Wisconsin for overall cardiac services and vascular surgery. The study, the largest of its kind, analyzed patient outcomes at virtually all of the nation's 5,000 hospitals.
About Aspirus
Aspirus is a non-profit, community-directed health system based in Wausau, Wis. With more than 3,900 employees, Aspirus serves people in 14 Wisconsin counties and the Upper Peninsula of Michigan through an affiliated hospital and physician network; home health and hospice care; skilled nursing homes; pharmacies; critical care and helicopter transport services; durable medical goods; a large volunteer corps; a philanthropic and research foundation; and an extensive clinics network.
Contacts:
Andy Napgezek, Communications/Public Relations Manager
Aspirus Wausau Hospital
715-847-2194
Greg Aune, Media/Communications Specialist
Aspirus Wausau Hospital
715-847-0479
###
Related Themes:
Pulmonary Heart Disease
pulmonary heart disease
Leading a Heart Healthy Lifestyle is Important For Women of Every Age
Long considered a man's problem, heart disease now affects more females than males Heart disease is responsible for 52 percent of all deaths in American women, claiming 250,000 female lives every year - more than all forms of cancer
Heart Rate Monitor
A heart rate monitor is a device that records or takes note of the heart's action and pulse There are different types of heart rate monitors that can assist you through your workouts without the risk of overworking your heart
Heart rate monitor devices have changed overtime
What Are the Causes of Heart Disease?
Millions of Americans suffer from it, but what really are the causes of heart disease There is almost as many myths and misinformation about the causes of heart disease as there are actual causes
List Of Heart Diseases
Lists of Heart Disease
A Cardio Twist to Blast Through Your Fat Loss Plateau
Copyright (c) 2010 Bryan Carlton
M2S to Sponsor Dinner Symposium on Vascular Quality Improvement Registries at Vascular Annual Meeting
M2S Inc., a Clinical Technology Organization and industry leader in endovascular treatment planning and patient data registries, announced today that the company will sponsor a dinner symposium titled "Vascular Quality Improvement Registries" at the 2009 Vascular Annual Meeting on June 12, 2009 in Denver, Colorado. The symposium will demonstrate how participation in a multi-center cooperative patient data registry can improve vascular healthcare, highlighting the six-year experience of the Vascular Study Group of Northern New England (VSGNNE). Participants will learn what to expect from, and how to set up, their own regional registries.
